Aktis Oncology, Inc. (AKTS) has 88 open-market insider trades by 25 insiders since 2017. Over the last six months insiders net sold $3.0M. The most active filer is Jeffrey B. Shealy, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | Dir | — | 1 | $40.0M | 2026-01-12 |
| Oleg Nodelman | Dir | — | 1 | $40.0M | 2026-01-12 |
| Ansbert Gadicke | 10% Owner | — | 1 | $20.0M | 2026-01-12 |
| MPM Oncology Innovations FUND L.P. | 10% | — | 1 | $20.0M | 2026-01-12 |
| Helen Susan Kim | Dir10% Owner | — | 1 | $15.0M | 2026-01-12 |
| Ventures Ii-a Llc Vida | 10% | — | 1 | $15.0M | 2026-01-12 |
| Jeffrey B. Shealy | CEO | — | 21 | $12.8M | 2024-01-29 |
| Todd Foley | Dir10% Owner | — | 1 | $4.2M | 2026-01-12 |
| Jeffrey Shealy | CEO | — | 1 | $3.3M | 2017-09-27 |
| Jerry D. Neal | Dir | — | 3 | $2.0M | 2023-11-06 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Akos Czibere | — | Sell | $259K | 2026-09-23 |
| Ken Herrmann | Director | Sell | $119K | 2026-07-20 |
| Ken Herrmann | Director | Sell | $77K | 2026-07-17 |
| Shulamit Ron-Bigger | COO | Sell | $1.4M | 2026-07-08 |
| Akos Czibere | — | Sell | $1.4M | 2026-07-08 |
| Todd Foley | Director & 10% Owner | Buy | $4.2M | 2026-01-12 |
Companies that share insiders with AKTS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Ansbert Gadicke | 10% Owner | Buy | $20.0M | 2026-01-12 |
| Ventures Ii-a Llc Vida | 10% | Buy | $15.0M | 2026-01-12 |
| Oleg Nodelman | Director | Buy | $40.0M | 2026-01-12 |
| David Aichele | EVP of Business Development | Buy | $40K | 2024-01-29 |
| Kenneth Boller | CFO | Buy | $30K | 2024-01-29 |
| Arthur Geiss | Director | Buy | $25K | 2024-01-29 |
| Jeffrey B. Shealy | CEO | Buy | $655K | 2024-01-29 |
| David Aichele | EVP of Business Development | Sell | $1K | 2023-12-18 |
| Kenneth Boller | CFO | Sell | $864 | 2023-12-18 |